NCT06203652

The Pathogenesis and Prognostic Factors of Lymphoma

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 2,000 (estimated)
• Sponsor: Shanghai Zhongshan Hospital · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The aim of this study is to describe the clinical and genetic characteristics of Chinese lymphoma patients, and to explore the relationship between those characteristics and phatogenesis.

Detailed description

Lymphoma is a highly common malignant tumor in Asia. This study aims to observe and describe the clinical and genetic charateristics of Chinese lymphoma patients, and to explore the relationship between those charateristics and pathogenesis and prognostic factors in the real-world population. This study is a non-interventional real world, observational study and all registered data are collected from real clinical practice cases. The medical data includes patient demographic, tumor characteristics, laboratory examination, history of treatments, adverse reactions, efficacy results and possible prognostic factors.

Conditions

• Lymphoma
• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Interventions

Type	Name	Description
OTHER	Real-world regimen	The final personalized management strategy is determined based on current conventional treatment options, physician and patient preferences.The following protocols: chemotherapy, immunochemotherapy,Anti-cd20 monoclonal antibody, BTKi and so on

Timeline

• Start date: 2023-06-05
• Primary completion: 2027-12-31
• Completion: 2028-12-31
• First posted: 2024-01-12
• Last updated: 2024-01-12

Locations

1 site across 1 country: China